跳至主要内容
临床试验/IRCT2016100925895N5
IRCT2016100925895N5已完成1 期

The evaluation of the effect of verapamil on insulin resistance and fasting blood sugar

Vice Chancellor for research of Arak University of Medical Sciences0 个研究点目标入组 73 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
73

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 75 years(—)
性别
All

入选标准

  • Type two diabetes; systolic blood pressure greater than 140 and less than 160 or diastolic blood pressure greater than 90 mmHg; age between 25-75 years old; intake of any oral drugs of diabetes; HbA1c between 7-8.5%
  • Exclusion criteria:
  • Low blood pressure; heart and brain disease; pregnancy; lactation; plan to pregnancy; intake of insulin; drugs such as contraceptive or etrogen or testosterone during past three months; chronic disease such as lung, renal, liver or GI; HbA1c between 7-8.5%; systolic blood pressure greater than 160 mmHg

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of Arak University of Medical Sciences

相似试验

The effect of verapamil on diabetes | 临床试验